Agios Pharmaceuticals Inc (NASDAQ: AGIO) started the day on Wednesday, with a price increase of 18.63% at $29.17, before settling in for the price of $24.59 at the close. Taking a more long-term approach, AGIO posted a 52-week range of $22.24-$46.00.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -160.69%. This publicly-traded company’s shares outstanding now amounts to $58.28 million, simultaneously with a float of $54.95 million. The organization now has a market capitalization sitting at $1.70 billion. At the time of writing, stock’s 50-day Moving Average stood at $34.53, while the 200-day Moving Average is $34.29.
Agios Pharmaceuticals Inc (AGIO) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Agios Pharmaceuticals Inc’s current insider ownership accounts for 5.77%, in contrast to 101.98% institutional ownership. According to the most recent insider trade that took place on Nov 12 ’25, this organization’s Director sold 200 shares at the rate of 43.84, making the entire transaction reach 8,768 in total value, affecting insider ownership by 17,603. Preceding that transaction, on Nov 11 ’25, Company’s Chief Medical Officer sold 2,454 for 43.78, making the whole transaction’s value amount to 107,436. This particular insider is now the holder of 61,727 in total.
Agios Pharmaceuticals Inc (AGIO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.84 per share during the current fiscal year.
Agios Pharmaceuticals Inc’s EPS decrease for this current 12-month fiscal period is -160.69% and is forecasted to reach -6.48 in the upcoming year.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Trading Performance Indicators
Let’s observe the current performance indicators for Agios Pharmaceuticals Inc (AGIO). It’s Quick Ratio in the last reported quarter now stands at 13.39. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 37.98.
In the same vein, AGIO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -6.96, a figure that is expected to reach -1.95 in the next quarter, and analysts are predicting that it will be -6.48 at the market close of one year from today.
Technical Analysis of Agios Pharmaceuticals Inc (AGIO)
If we take a close look at the recent performances of Agios Pharmaceuticals Inc (NASDAQ: AGIO), its last 5-days Average volume was 2.95 million that shows progress from its year to date volume of 0.9 million. During the previous 9 days, stock’s Stochastic %D was recorded 37.83% While, its Average True Range was 60.19.
Raw Stochastic average of Agios Pharmaceuticals Inc (AGIO) in the period of the previous 100 days is set at 29.17%, which indicates a major fall in contrast to 85.21% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.22 that was lower than 1.58 volatility it exhibited in the past 100-days period.
